New poxvirus drug candidate tested in healthy people
NCT ID NCT07377175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests the safety and how the body processes a new drug called BSY001 in 76 healthy adults aged 18 to 50. Participants receive either the drug or a placebo, and researchers monitor side effects and drug levels in the blood. The goal is to gather safety information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COWPOX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Shulan (Hangzhou) Hospital
RECRUITINGHangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smallpox vaccine stop mpox in its tracks?
- Experimental drug targets smallpox and monkeypox after exposure
- Monkeypox vaccine immune response under the microscope
- Can a pill speed up monkeypox recovery? major trial underway
- Scientists investigate mpox in severely weakened immune systems
- Could a smaller dose of monkeypox vaccine work just as well?